Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | WRN | Q14191 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
| ▸ | BCL9 | O00512 | 1/20 | 0.30 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7158605 | 0.85 | LMNA (0.43) | RECQLALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL9499558 | 0.81 | NAAA (0.40) | RECQLALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL5576745 | 0.80 | LMNA (0.37) | ALDH1A1LMNAKMT2AMAPTSMN1; SMN2 | |
| SCHEMBL6516909 | 0.77 | NAAA (0.34) | RECQLALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL19258739 | 0.76 | NAAA (0.33) | RECQLALDH1A1CYP1A2HPGDCYP2C19 | |
| Debropol SCHEMBL28989479 | 0.74 | LMNA (0.37) | ALDH1A1LMNAMAPT | |
| SCHEMBL1326486 | 0.69 | NAAA (0.44) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| SCHEMBL722286 | 0.68 | NAAA (0.43) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| SCHEMBL14472846 | 0.68 | NAAA (0.43) | ALDH1A1CYP1A2HPGDCYP2C19BLM | |
| SCHEMBL15281013 | 0.68 | LMNA (0.45) | ALDH1A1CYP1A2HPGDCYP2C19BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10983615-B2 | Patterning of a composition comprising silver nanowires | Heraeus Deutschland GmbH & Co. KG (DE) | 2021-04-20 | — | — | US | disclosed |
| US-10671192-B2 | Process for the production of a layered body and layered bodies obtainable therefrom | Heraeus Deutschland GmbH & Co. KG (DE) | 2020-06-02 | — | — | US | disclosed |
| EP-2729845-B1 | PROCESS FOR THE PRODUCTION OF A LAYERED BODY | HERAEUS DEUTSCHLAND GMBH & CO KG (DE) | 2019-09-04 | — | — | EP | disclosed |
| US-20180341346-A1 | PATTERNING OF A COMPOSITION COMPRISING SILVER NANOWIRES | HERAEUS DEUTSCHLAND GMBH & CO KG (DE) | 2018-11-29 | — | — | US | disclosed |
| US-10073549-B2 | Patterning of a composition comprising silver nanowires | Heraeus Deutschland GmbH & Co. KG (DE) | 2018-09-11 | — | — | US | disclosed |
| US-20160162063-A1 | PATTERNING OF A COMPOSITION COMPRISING SILVER NANOWIRES | Heraeus Deutschland GmbH & Co. KG (DE) | 2016-06-09 | — | — | US | disclosed |
| EP-2638547-B1 | METHOD FOR PRODUCING LAYER STRUCTURES BY TREATMENT WITH ORGANIC ETCHANTS AND LAYER STRUCTURES OBTAINABLE THEREFROM | HERAEUS DEUTSCHLAND GMBH & CO KG (DE) | 2015-07-08 | — | — | EP | disclosed |
| WO-2015010778-A1 | PATTERNING OF A COMPOSITION COMPRISING SILVER NANOWIRES | HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) | 2015-01-29 | — | — | WO | disclosed |
| EP-2830110-A1 | Patterning of a composition comprising silver nanowires | Heraeus Precious Metals GmbH & Co. KG (DE) | 2015-01-28 | — | — | EP | disclosed |
| US-20140313433-A1 | Process for the Production of a Layered Body and Layered Bodies Obtainable Therefrom | HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) | 2014-10-23 | — | — | US | disclosed |
| US-20140242350-A1 | Process For The Production Of A Layered Body And Layered Bodies Without Masking Obtainable Therefrom | HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) | 2014-08-28 | — | — | US | disclosed |
| EP-2729846-A1 | PROCESS FOR THE PRODUCTION OF A LAYERED BODY AND LAYERED BODIES WITHOUT MASKING OBTAINABLE THEREFROM | Heraeus Precious Metals GmbH & Co. KG (DE) | 2014-05-14 | — | — | EP | disclosed |
| EP-2729845-A1 | PROCESS FOR THE PRODUCTION OF A LAYERED BODY AND LAYERED BODIES OBTAINABLE THEREFROM | Heraeus Precious Metals GmbH & Co. KG (DE) | 2014-05-14 | — | — | EP | disclosed |
| US-20130295354-A1 | METHOD FOR PRODUCING LAMINATED ARTICLES BY TREATMENT WITH ORGANIC ETCHANTS AND LAMINATED ARTICLES OBTAINABLE THEREFROM | HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) | 2013-11-07 | — | — | US | disclosed |
| WO-2013007362-A1 | PROCESS FOR THE PRODUCTION OF A LAYERED BODY AND LAYERED BODIES OBTAINABLE THEREFROM | HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) | 2013-01-17 | — | — | WO | disclosed |
| WO-2013007363-A1 | PROCESS FOR THE PRODUCTION OF A LAYERED BODY AND LAYERED BODIES WITHOUT MASKING OBTAINABLE THEREFROM | HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) | 2013-01-17 | — | — | WO | disclosed |
| US-6881418-B2 | Microbicidal deodorant in a tractable liquid form that has excellent longterm storage stability. The microbicidal deodorant of the present invention comprises: at least one substance selected from the group consisting of halogenated | K.I CHEMICAL INDUSTRY CO., LTD. (JP) | 2005-04-19 | — | — | US | disclosed |
| EP-1393628-A1 | LIQUID DEODORANT KILLING MICROORGANISM AND METHOD OF MICROORGANISM-KILLING DEODORIZATION | K I CHEMICAL INDUSTRY CO., LTD. (JP) | 2004-03-03 | — | — | EP | disclosed |
| JP-2003261518-A | NEW DIBROMONITROALCOHOL DERIVATIVE AND APPLICATION THEREOF | K I CHEMICAL INDUSTRY CO LTD | 2003-09-19 | — | — | JP | disclosed |
| US-20030157051-A1 | Liquid deodorant killing microorganism and method of microorganism-killing deodorization | K.I. CHEMICAL INDUSTRY CO., LTD. (JP) | 2003-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030157051-A1 | Liquid deodorant killing microorganism and method of microorganism-killing deodorization | DAO, DDT, DIMT1 | RECQL 2783/4885ALDH1A1 94/4885CYP1A2 666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.